Related Experiment Video
Updated: Mar 6, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Health-related quality of life among children with hereditary angioedema
Batya Engel-Yeger1, Henriette Farkas2, Shmuel Kivity3
1Department Faculty of Social Welfare and Health Sciences, University of Haifa Occupational Therapy, Haifa, Israel.
Insights
Children with symptomatic hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) experience significantly lower quality of life. Health-related quality of life is negatively impacted by attack frequency and location, particularly affecting school and physical well-being.
Area of Science:
- Pediatrics
- Immunology
- Genetics
Background:
- Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) significantly impacts patients' quality of life.
- Assessing health-related quality of life (HRQoL) in pediatric C1-INH-HAE patients is crucial for understanding disease burden.
Purpose of the Study:
- To evaluate the health-related quality of life (HRQoL) in children diagnosed with C1-INH-HAE.
- To compare HRQoL between pediatric C1-INH-HAE patients and healthy controls.
Main Methods:
- A cross-sectional study involving 34 children with C1-INH-HAE and 64 healthy controls aged 3-18 years.
- HRQoL was assessed using the Pediatric Quality of Life Inventory (PedsQL™) 4.0 Generic Core Scales.
- Disease activity and attack sites were recorded to correlate with HRQoL outcomes.
Main Results:
- Children with C1-INH-HAE attacks reported lower overall HRQoL, including school and psychosocial dimensions, compared to controls.
- A higher frequency of C1-INH-HAE attacks correlated negatively with total, school-related, and psychosocial HRQoL scores.
- Multisite attacks (laryngeal, abdominal, peripheral) resulted in significantly lower HRQoL across total, physical, and school domains compared to solely peripheral attacks.
Conclusions:
- Symptomatic pediatric C1-INH-HAE is associated with impaired health-related quality of life.
- The frequency and location of C1-INH-HAE attacks are key determinants of reduced HRQoL in children.
- School and physical domains are most affected by C1-INH-HAE attacks, highlighting the need for targeted interventions.
Background:
The clinical expressions of hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) and its related burden may negatively affect patient quality of life. This study aimed to assess health-related quality of life (HRQoL) in children with C1-INH-HAE.
Methods:
Children (N = 98: 34 C1-INH-HAE patients, 64 healthy controls) aged 3-18 years were recruited in Israel and Hungary. All individuals completed a demographic questionnaire, a disease activity and site questionnaire, and the Pediatric Quality of Life Inventory (PedsQL™) 4.0 Generic Core Scales (child self-report and maternal proxy report) to assess HRQoL.
Results:
Among C1-INH-HAE patients, nine (26.5%) had 1-5 attacks/year, six (17.6%) had 6-18 attacks/year, eight (23.5%) had 25-60 attacks/year, and 11 (32.4%) were asymptomatic over the previous year. Children with C1-INH-HAE attacks demonstrated lower HRQoL than healthy control children across the total score, school, and psychosocial dimensions of the PedsQL™. The number of C1-INH-HAE attacks negatively correlated with the total HRQoL score (r = -0.48, p = 0.008), school-related HRQoL (r = -0.39, p = 0.02), and psychosocial HRQoL (r = -0.43, p = 0.01). Patients with multisite laryngeal, abdominal, and peripheral C1-INH-HAE attacks had a lower HRQoL compared with those who experienced solely peripheral attacks across the total score (p = 0.04), physical (p = 0.04), and school (p = 0.02) domains. There was no significant difference between asymptomatic C1-INH-HAE patients and healthy controls.
Conclusions:
Children with symptomatic C1-INH-HAE demonstrate impaired HRQoL compared with healthy controls. HRQoL was affected by the frequency and site of C1-INH-HAE attacks and mostly in the school and physical domains.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Asthma-III: Symptoms and Complications
Classification of Asthma
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management

